Developer docs
API playgroundTry for free, no card

Search company profiles

Allied BioScience

Full company profile

uuid000euic

Namestring
Allied BioScience
Legal namestring
Allied BioScience
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Allied BioScience is a Dallas-based company operating a direct-to-consumer e-commerce storefront that sells research peptides, GLP-1 receptor agonists, and human growth hormone products to individual consumers. Founded in 2005 and originally associated with a B2B antiviral surface-coating technology (SurfaceWise2), the company has shifted its operational focus toward an online retail model selling semaglutide, tirzepatide, and retatrutide vials and pre-filled pens, alongside performance peptides (BPC-157, GHRP-2/6, Ipamorelin, TB-500, IGF-1 LR3, NAD+) and HGH brands (Zptropin, Genotropin, Omnitrope, Ngenla, Somatropin, Spectros). Products are sourced from third-party manufacturers including ZPHC and Spectrum Pharma (USA) and Turkish pharma brands (Turkey), shipped from warehouses in both geographies, and listed at unit prices ranging from roughly $110 to $1,701, with multi-kit bundle discounts of 15-30%. The proprietary technical differentiators are dual-chamber pen delivery systems for retatrutide and pre-mixed pen formats with click-dosing for tirzepatide and retatrutide that eliminate user reconstitution. Products are sold without prescription verification and target three primary personas: weight-loss seekers, bodybuilders and performance-focused athletes, and anti-aging/wellness buyers. Distribution is exclusively through the owned alliedbioscience.com storefront, with no retail, wholesale, or marketplace presence. The company is privately held, backed by Capital7 following a Series C of over $80 million closed in May 2021, and operates with an 11-50 employee headcount across Dallas headquarters and two warehouses (USA and Turkey).

Short descriptiontext

Allied BioScience is a Dallas-based direct-to-consumer e-commerce retailer selling research peptides, GLP-1 agonists, and human growth hormone products to individual consumers in the U.S. and international markets, without prescription verification.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPlano, United States
HQ citystring
Plano
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
weight loss peptides, human growth hormone, GLP-1 medications, performance peptides, specialty pharmaceuticals retail
Industry2 codes
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)
NAICS code1 code
  • Food (Health) Supplement Retailers456191
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals Retail
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct Product Sales
TypeOne Time License
Description

Direct-to-consumer sales of peptides and HGH products through e-commerce storefront. Revenue generated from one-time purchases with volume discount incentives encouraging larger orders. Repeat customers are encouraged through bundle pricing and loyalty-building discount tiers (2-20+ vials with progressive discounts).

alliedbioscience.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Pricing details4 tiers
1GLP-1 Products (Semaglutide, Tirzepatide, Retatrutide) - $105-$1,701 per unit/bundle
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Semaglutide 2mg: $105-$180 (20+ units); Semaglutide 5mg: $139-$249; Tirzepatide 37.5mg Kit: $345; Tirzepatide 50mg Kit: $395; Retatrutide 20mg: $250-$280; Retatrutide Premixed Pen 30mg: $250-$290; Retatrutide Dual-Chamber Pens: $490-$580

alliedbioscience.com
2HGH Products - $110-$880 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

HP-HCG 5000 IU: $110; ZPtrop AQ 36 IU pen: $125; Somatropin 191aa 150 IU kit: $365; Spectros 140 IU kit: $305; Spectros 280 IU: $590; Zptropin 160 IU kit: $365; Zptropin 200 IU: $420; Genotropin 36 IU: $325; Omnitrope 45 IU: $285; Ngenla 72 IU: $385; Ngenla 180 IU: $880

alliedbioscience.com
3Performance Peptides - $120-$295 per unit
ModelUnit PricingBilling cadencePay-as-you-go
Notes

BPC 157 25mg: $195; GHRP-2 25mg: $195; GHRP-6 25mg: $195; Ipamorelin 25mg: $120; TB-500 25mg: $275; IGF-1 LR3 1mg: $210; NAD+ 2500mg Kit: $195; MEGA MASS MIX 50mg: $295; ULTRA REHAB MIX 50mg: $295; WELLNESS MIX 25mg: $195

alliedbioscience.com
4Bundle Discounts - 15-30% savings on multi-kit purchases
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Tirzepatide bundles: 2-kit (-15%), 3-kit (-20%), 4-kit (-25%), 5-kit (-30%). Semaglutide bundles: Buy 1 Get 1 Free + tiered pricing with increasing savings at higher quantities.

alliedbioscience.com
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Allied BioScience operates as a direct-to-consumer online retailer selling peptides, GLP-1 receptor agonists (Semaglutide, Tirzepatide, Retatrutide), human growth hormone (HGH) products, and pre-formulated peptide stacks for weight loss, bodybuilding/performance, and anti-aging use. Products are sourced from manufacturers including ZPHC, Spectrum Pharma, Pfizer (Genotropin, Ngenla), and Sandoz (Omnitrope) and shipped from US and Turkey warehouses. The company emphasizes third-party lab testing, authenticity verification, and volume discount pricing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Semaglutide 5 mg lab-tested purity of 99.657%
+4 more records
Product overview1 text field

Allied BioScience is an online retailer specializing in peptides and human growth hormone (HGH) products for weight loss, performance, and health optimization. The product portfolio consists of three main categories: GLP-1 peptides including Semaglutide (2 mg and 5 mg vials), Tirzepatide (37.5 mg and 50 mg kits in both vial and premixed pen formats), and Retatrutide (various strengths in dual-chamber and premixed pen formats); Health Performance Peptides including BPC 157, GHRP-2, GHRP-6, Ipamorelin, TB-500, NAD+, and IGF-1 LR3, as well as pre-formulated stacks like MEGA MASS MIX (GHRP-2 + CJC-1295), ULTRA REHAB MIX (BPC-157 + TB-500), and WELLNESS MIX (Ipamorelin + CJC-1295); and Human Growth Hormone products from multiple brands including Zptropin, Genotropin (Pfizer), Omnitrope (Sandoz), Ngenla (Pfizer/somatrogon), Somatropin 191aa, and Spectros. Products are sold directly to consumers with various delivery formats including vials requiring reconstitution, dual-chamber pens that mix upon use, and pre-mixed pen systems.

Product and service3 records
1Semaglutide
CategoryGLP-1 Peptide
Description

GLP-1 receptor agonist available in 2 mg and 5 mg freeze-dried vial formats for weight loss and blood sugar regulation. Requires reconstitution with bacteriostatic water before use. Sold as individual units and as a Buy 1 Get 1 bundle ranging $105–$1,701.

2Tirzepatide Kits and Pens
CategoryGLP-1 Peptide
Description

Dual GLP-1/GIP receptor agonist offered in 37.5 mg kits (5 vials of 7.5 mg), 50 mg kits (5 vials of 10 mg), and 30 mg pre-mixed pen formats with micro-dial precision dosing and multi-pack bundle pricing ranging $345–$1,383.

3Retatrutide
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeBroad incumbent
Description

Telehealth company offering branded GLP-1 weight-loss programs (Ro Body) with bundled pricing and ongoing care, directly overlapping Allied BioScience's primary weight-loss customer segment via a compliant dispensing model.

2Limitless Life Nootropics
TypeDirect peer
Description

D2C retailer of nootropics, wellness, and research-grade peptide supplements with similar pricing tiers, bundle discounts, and gray-market positioning. Direct comparable on performance peptide and wellness SKUs.

TypeDirect peer
Description

Online retailer offering research chemicals and peptides positioned as 'for research purposes only,' operating with a comparable gray-market compliance posture and pricing strategy.

TypeDirect peer
Description

Direct-to-consumer telehealth and online pharmacy focused on GLP-1 weight-loss medications, operating in an adjacent compliance posture. Highly comparable customer base, GTM motion, and product line to Allied BioScience.

TypeEmerging player
Description

Specialized online retailer of reconstitution supplies and ancillary products sold alongside peptides. Operates in the same DIY peptide self-administration ecosystem that supplies Allied BioScience's customers.

TypeDirect peer
Description

Online retailer offering research-grade peptides including BPC-157 and other recovery compounds targeted at the same bodybuilding and longevity consumer segments.

TypeDirect peer
Description

Established online retailer of research-grade peptides (BPC-157, TB-500, Ipamorelin and others) sold without prescription for research use. Highly comparable catalog, pricing, and customer demographic to Allied BioScience's performance peptide line.

TypeDirect peer
Description

Online pharmacy specializing in GLP-1 weight-loss medications including Semaglutide and Tirzepatide with telehealth consultations. Direct competitor in the same niche consumer segment.

TypeBroad incumbent
Description

Manufacturer of branded GLP-1 therapies (Zepbound, Mounjaro) now selling direct to consumer through LillyDirect platform. Represents both an upstream supplier relationship (compounds Allied BioScience sells) and a competitive threat that could disintermediate gray-market sellers once supply normalizes.

TypeBroad incumbent
Description

Public telehealth platform that sells GLP-1 medications (Semaglutide, Tirzepatide) directly to consumers via online consultations and prescriptions. Allied BioScience competes in the same GLP-1 e-commerce category but without prescription verification, making Hims & Hers the closest legitimate-market comparable.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Allied BioScience

Specialty Pharmaceuticals Retailalliedbioscience.com

Allied BioScience is a Dallas-based direct-to-consumer e-commerce retailer selling research peptides, GLP-1 agonists, and human growth hormone products to individual consumers in the U.S. and international markets, without prescription verification.

What Allied BioScience does

Allied BioScience is a Dallas-based company operating a direct-to-consumer e-commerce storefront that sells research peptides, GLP-1 receptor agonists, and human growth hormone products to individual consumers. Founded in 2005 and originally associated with a B2B antiviral surface-coating technology (SurfaceWise2), the company has shifted its operational focus toward an online retail model selling semaglutide, tirzepatide, and retatrutide vials and pre-filled pens, alongside performance peptides (BPC-157, GHRP-2/6, Ipamorelin, TB-500, IGF-1 LR3, NAD+) and HGH brands (Zptropin, Genotropin, Omnitrope, Ngenla, Somatropin, Spectros). Products are sourced from third-party manufacturers including ZPHC and Spectrum Pharma (USA) and Turkish pharma brands (Turkey), shipped from warehouses in both geographies, and listed at unit prices ranging from roughly $110 to $1,701, with multi-kit bundle discounts of 15-30%. The proprietary technical differentiators are dual-chamber pen delivery systems for retatrutide and pre-mixed pen formats with click-dosing for tirzepatide and retatrutide that eliminate user reconstitution. Products are sold without prescription verification and target three primary personas: weight-loss seekers, bodybuilders and performance-focused athletes, and anti-aging/wellness buyers. Distribution is exclusively through the owned alliedbioscience.com storefront, with no retail, wholesale, or marketplace presence. The company is privately held, backed by Capital7 following a Series C of over $80 million closed in May 2021, and operates with an 11-50 employee headcount across Dallas headquarters and two warehouses (USA and Turkey).

Allied BioScience firmographics

Firmographics
Name
Allied BioScience
Legal name
Allied BioScience
Website
https://alliedbioscience.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
Allied BioScience is a Dallas-based direct-to-consumer e-commerce retailer selling research peptides, GLP-1 agonists, and human growth hormone products to individual consumers in the U.S. and international markets, without prescription verification.
Ownership category
akta.pro rank

Allied BioScience industry classification

Industry
Product category
Specialty Pharmaceuticals Retail
NAICS
Food (Health) Supplement Retailers (456191)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAAAH
Therapeutic Peptides & Protein/Peptide Biologics
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYAFAJAKAG
Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine)
Agriculture & Food Production/Food Ingredients & Additives/Nutraceutical & Functional Ingredients (Vitamins, Minerals, Omega-3s, Botanicals)

Keywords

  • Weight loss peptides
  • Human growth hormone
  • GLP-1 medications
  • Performance peptides
  • Specialty pharmaceuticals retail

Where Allied BioScience is headquartered

Location

Headquarters

HQ city
Plano
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Allied BioScience business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

  1. Direct Product Sales: Direct-to-consumer sales of peptides and HGH products through e-commerce storefront. Revenue generated from one-time purchases with volume discount incentives encouraging larger orders. Repeat customers are encouraged through bundle pricing and loyalty-building discount tiers (2-20+ vials with progressive discounts).

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGLP-1 Products (Semaglutide, Tirzepatide, Retatrutide) - $105-$1,701 per unit/bundle
Unit PricingPay-as-you-goHGH Products - $110-$880 per unit
Unit PricingPay-as-you-goPerformance Peptides - $120-$295 per unit
Unit PricingPay-as-you-goBundle Discounts - 15-30% savings on multi-kit purchases

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Allied BioScience product offering

Product offering

Core offering

Allied BioScience operates as a direct-to-consumer online retailer selling peptides, GLP-1 receptor agonists (Semaglutide, Tirzepatide, Retatrutide), human growth hormone (HGH) products, and pre-formulated peptide stacks for weight loss, bodybuilding/performance, and anti-aging use. Products are sourced from manufacturers including ZPHC, Spectrum Pharma, Pfizer (Genotropin, Ngenla), and Sandoz (Omnitrope) and shipped from US and Turkey warehouses. The company emphasizes third-party lab testing, authenticity verification, and volume discount pricing.

Product overview

Allied BioScience is an online retailer specializing in peptides and human growth hormone (HGH) products for weight loss, performance, and health optimization. The product portfolio consists of three main categories: GLP-1 peptides including Semaglutide (2 mg and 5 mg vials), Tirzepatide (37.5 mg and 50 mg kits in both vial and premixed pen formats), and Retatrutide (various strengths in dual-chamber and premixed pen formats); Health Performance Peptides including BPC 157, GHRP-2, GHRP-6, Ipamorelin, TB-500, NAD+, and IGF-1 LR3, as well as pre-formulated stacks like MEGA MASS MIX (GHRP-2 + CJC-1295), ULTRA REHAB MIX (BPC-157 + TB-500), and WELLNESS MIX (Ipamorelin + CJC-1295); and Human Growth Hormone products from multiple brands including Zptropin, Genotropin (Pfizer), Omnitrope (Sandoz), Ngenla (Pfizer/somatrogon), Somatropin 191aa, and Spectros. Products are sold directly to consumers with various delivery formats including vials requiring reconstitution, dual-chamber pens that mix upon use, and pre-mixed pen systems.

Differentiator

Problem solved

Functional benefit

Products and services

  • Semaglutide GLP-1 receptor agonist available in 2 mg and 5 mg freeze-dried vial formats for weight loss and blood sugar regulation. Requires reconstitution with bacteriostatic water before use. Sold as individual units and as a Buy 1 Get 1 bundle ranging $105–$1,701.
  • Tirzepatide Kits and Pens Dual GLP-1/GIP receptor agonist offered in 37.5 mg kits (5 vials of 7.5 mg), 50 mg kits (5 vials of 10 mg), and 30 mg pre-mixed pen formats with micro-dial precision dosing and multi-pack bundle pricing ranging $345–$1,383.
  • Retatrutide

Quantifiable outcome

  • Semaglutide 5 mg lab-tested purity of 99.657%
  • +4 more outcomes

Companies that use Allied BioScience

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Allied BioScience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Allied BioScience partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Allied BioScience competitors and assessment

Company assessment

Broad incumbents

  • Ro: Telehealth company offering branded GLP-1 weight-loss programs (Ro Body) with bundled pricing and ongoing care, directly overlapping Allied BioScience's primary weight-loss customer segment via a compliant dispensing model.
  • Eli Lilly (LillyDirect): Manufacturer of branded GLP-1 therapies (Zepbound, Mounjaro) now selling direct to consumer through LillyDirect platform. Represents both an upstream supplier relationship (compounds Allied BioScience sells) and a competitive threat that could disintermediate gray-market sellers once supply normalizes.
  • Hims & Hers Health: Public telehealth platform that sells GLP-1 medications (Semaglutide, Tirzepatide) directly to consumers via online consultations and prescriptions. Allied BioScience competes in the same GLP-1 e-commerce category but without prescription verification, making Hims & Hers the closest legitimate-market comparable.

Direct peers

  • Limitless Life Nootropics: D2C retailer of nootropics, wellness, and research-grade peptide supplements with similar pricing tiers, bundle discounts, and gray-market positioning. Direct comparable on performance peptide and wellness SKUs.
  • Swiss Chems: Online retailer offering research chemicals and peptides positioned as 'for research purposes only,' operating with a comparable gray-market compliance posture and pricing strategy.
  • Henry Meds: Direct-to-consumer telehealth and online pharmacy focused on GLP-1 weight-loss medications, operating in an adjacent compliance posture. Highly comparable customer base, GTM motion, and product line to Allied BioScience.
  • Blue Sky Peptide: Online retailer offering research-grade peptides including BPC-157 and other recovery compounds targeted at the same bodybuilding and longevity consumer segments.
  • Peptide Sciences: Established online retailer of research-grade peptides (BPC-157, TB-500, Ipamorelin and others) sold without prescription for research use. Highly comparable catalog, pricing, and customer demographic to Allied BioScience's performance peptide line.
  • Emerge Medical: Online pharmacy specializing in GLP-1 weight-loss medications including Semaglutide and Tirzepatide with telehealth consultations. Direct competitor in the same niche consumer segment.

Emerging players

  • Bacteriostatic Water (peptide retail segment): Specialized online retailer of reconstitution supplies and ancillary products sold alongside peptides. Operates in the same DIY peptide self-administration ecosystem that supplies Allied BioScience's customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Allied BioScience social profiles

Digital presence

Allied BioScience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Allied BioScience leadership team

Management profile

Number of profiles

Profiles5 records

Allied BioScience funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Allied BioScience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allied BioScience

What does Allied BioScience do?

Allied BioScience operates as a direct-to-consumer online retailer selling peptides, GLP-1 receptor agonists (Semaglutide, Tirzepatide, Retatrutide), human growth hormone (HGH) products, and pre-formulated peptide stacks for weight loss, bodybuilding/performance, and anti-aging use. Products are sourced from manufacturers including ZPHC, Spectrum Pharma, Pfizer (Genotropin, Ngenla), and Sandoz (Omnitrope) and shipped from US and Turkey warehouses. The company emphasizes third-party lab testing, authenticity verification, and volume discount pricing.

Is Allied BioScience a public or private company?

Allied BioScience is a private company. It is classified as private equity controlled and is currently operating.

When was Allied BioScience founded?

Allied BioScience was founded in 2005. It employs 1 to 10 people.

Where is Allied BioScience based?

Allied BioScience is headquartered in Plano, United States, in the North America region.

How does Allied BioScience make money?

One revenue line is on record: direct Product Sales.

Who are Allied BioScience's main competitors?

Broad incumbents on record are Ro, Eli Lilly (LillyDirect) and Hims & Hers Health. Direct peers are Limitless Life Nootropics, Swiss Chems, Henry Meds, Blue Sky Peptide, Peptide Sciences and Emerge Medical. Bacteriostatic Water (peptide retail segment) is listed as an emerging player.

Does Allied BioScience have an API?

No public API is recorded for Allied BioScience.

What industry is Allied BioScience in?

Allied BioScience's product category is Specialty Pharmaceuticals Retail. Its primary akta.pro industry code is HLAAAAAH, Therapeutic Peptides & Protein/Peptide Biologics, with a secondary code of AFAJAKAG, Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine). Its NAICS code is 456191 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LawbcEPA Orders Allied BioScience to Stop Selling and Distributing SurfaceWise2The EPA issued a Stop Sale, Use or Removal Order to Allied BioScience for its SurfaceWise2 product, requiring an immediate halt to sales and distribution. The agency revoked emergency exemptions for Arkansas, Texas, and Oklahoma, citing FIFRA violations and new efficacy data showing the product's performance is less reliable under real-world conditions.PR NewswireAllied BioScience Strengthens C-Suite Executive Team with Two Hires as Company Expands Global Business and Portfolio, Cements IP OwnershipAllied BioScience, a Dallas-based biotech company, announced the hiring of David Maxwell as Chief Financial Officer and Jennifer Keefe as Chief Legal Officer to support its global expansion of SurfaceWise2 and preparation for a Series A2 Preferred funding round. Jennifer Keefe's legal expertise was instrumental in settling a dispute with Mr. Craig Grossman, resulting in Allied BioScience retaining full intellectual property ownership over its product portfolio. The company is investing heavily in research and development to advance innovations beyond its flagship EPA-authorized surface coating.Dallas InnovatesCapital7 Invests in Dallas Biotech Allied BioScience's Series C Preferred StockCapital7 LLC has invested in Allied BioScience's Series C Preferred Stock, bringing the company's total funding to over $80 million. The funds will support the global expansion of its flagship product, SurfaceWise2, an EPA-approved antiviral surface coating, as well as regulatory approvals and new product development. This investment aims to accelerate market entry in international regions including Canada, Germany, and Australia.Dallas InnovatesCapital7 Invests in Dallas Biotech Allied BioScience's Series C Preferred StockDallas biotech Allied BioScience received an undisclosed Series C investment in preferred stock from private equity firm Capital7 LLC, closing at $5 per share in February for $5,725,000. The round brings total funding to more than $80 million and will fund global expansion, regulatory approval, next-generation products and marketing. The company's SurfaceWise2 coating, EPA-approved last August, destroys 99.9 percent of viruses on surfaces.PR NewswireCapital7 Invests in Leading Biotech Firm Allied BioScience to Support Growth, Company's Portfolio ExpansionMidwestern private equity firm Capital7, LLC has made an early-stage investment in Allied BioScience's Series C Preferred Stock to support the biotech company's growth and portfolio expansion. This funding supports Allied BioScience's efforts to expand its SurfaceWise2 antiviral coating technology globally and secure additional regulatory approvals.PR NewswireBiotech Firm Continues Focus on Saving Lives Through First-of-its-Kind Residual Product, Expands GloballyAllied BioScience, a Dallas-based biotech firm, is expanding the national and international availability of its SurfaceWise2™ antimicrobial surface coating after receiving expanded EPA emergency use authorization covering Texas, Oklahoma, and Arkansas. The company has strategic partnerships in Canada, Germany, Australia, India, and the UAE for distribution across transportation, healthcare, fitness, and retail sectors, with national approval expected in the coming months. Allied BioScience recently relocated its Plano headquarters to nearly double its office space to accommodate planned team expansion and product diversification in 2021.PR NewswireGlobal Antimicrobial Additives and Coatings Market Report 2021: Opportunities are Growing Fast Due to COVID-19 - Forecast to 2030ResearchAndMarkets has added a new market report titled "The Global Market for Antimicrobial Additives and Coatings to 2030" to its offerings, highlighting rapid growth in the sector driven by the global COVID-19 crisis. The report analyzes various antimicrobial technologies and their applications across healthcare, food packaging, and household surfaces, noting that previous cost barriers are becoming less significant due to increased demand for hygiene. It includes detailed assessments of end-user markets and profiles of key industry players such as Allied Bioscience and Bio-Gate AG.ApexDisinfectant Damage: Are Cleaning Products Harming Aircraft Interiors?American Airlines will use Allied BioScience's SurfaceWise2 disinfectant spray, but EPA review does not cover impact on cabin materials. Experts warn quaternary ammonium-based chemicals can erode adhesives and damage seat coverings, while UVC lighting offers an alternative. Cleanable surfaces are expected to become standard.PR NewswireIndustry-leading Biotech Firm Allied BioScience Moves Plano Offices to Support Growing TeamAllied BioScience, a Plano-based biotech company specializing in antimicrobial coatings, is relocating its Dallas-Fort Worth headquarters within Plano to double its square footage and accommodate rapid growth. The expansion follows the company's significant sales increases after receiving broader Environmental Protection Agency authorization for its SurfaceWise2 product, the first antiviral coating to receive EPA approval for continuous COVID-19 protection. The 12-year-old company plans to hire across all departments and diversify beyond surface coatings into a larger product portfolio.PR NewswirePureShield And ViaClean Technologies File Suit Against Allied BioScience For Patent Infringement, False Advertising, Unfair Competition & Tortious InterferenceViaClean Technologies and its subsidiary PureShield have filed a lawsuit against Allied BioScience in the U.S. District Court for the Eastern District of Texas, alleging infringement of ten U.S. patents along with claims of false advertising, unfair competition, and tortious interference with business relations. The lawsuit, filed by Crowell & Moring LLP, seeks damages and injunctive relief related to Allied BioScience's product lines including SurfaceWise2. ViaClean's BIOPROTECTUs System provides long-term antimicrobial surface protection of up to 90 days.